As the use of AI spreads through every industry and becomes more of a part of our lives every day, researchers are also ...
SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Spruce Biosciences, Inc. (Nasdaq: SPRB), a late-stage biopharmaceutical company focused on developing and commercializing novel therapies for neurological ...
Spruce Biosciences Receives U.S. FDA Breakthrough Therapy Designation for Tralesinidase Alfa Enzyme Replacement Therapy (TA-ERT) in Sanfilippo Syndrome Type B (MPS IIIB) Breakthrough Therapy ...
Sophie M Phillips is supported by the Canadian Institutes of Health Research (CIHR). Trish Tucker receives funding from the Canada Foundation of Innovation, Canadian Institutes of Health Research, ...
Tumors adapt to their environment to avoid detection. As different cancer treatments progress, tumors mutate and become resistant. Various markers are expressed on tumors that can be used to target in ...
Abstract: Enzyme assays are a cornerstone of basic biology and clinical diagnostics. While enzymatic assays are frequently used to indicate disease,[1] changes in enzyme activity can occur due to ...
In a breakthrough study, scientists found that silencing a single overactive enzyme in the brain reversed early damage caused by a Parkinson’s-related mutation in mice. The treatment restored the ...
Stanford researchers discovered that dialing down an overactive enzyme, LRRK2, can regrow lost cellular “antennae” in key brain cells, restoring vital dopamine communication and neuroprotective ...
ORONO — According to research recently released by the University of Maine Cooperate Extension Tick Lab, tick activity is “elevated” in Maine’s Midcoast counties. The lab recently published a research ...
It’s a common sentiment from English teachers facing an onslaught of AI-generated writing in their classrooms: When students rely on ChatGPT to write their essays, they aren’t engaging their brains as ...
- Clinically meaningful anti-tumor activity of ZL-1310 observed in heavily pretreated population of patients with small cell lung cancer (SCLC) across dose escalation and expansion cohorts - In second ...
Previously described engineered living materials (ELMs) have been created with nonresponsive, biocompatible polymers by adding living cells to a precursor solution before polymerization, which cells ...